- Companies
- Soley Therapeutics
Soley Therapeutics Funding, Investors & Competitors
Soley Therapeutics has raised $220M across 2 funding rounds, most recently a $200M Series C in January 2026.
Last Soley Therapeutics funding round
$200M
Series C · Jan 2026
Cumulative funding Soley Therapeutics raised
$220M
across 2 funding rounds
Key investors in Soley Therapeutics
Breyer Capital
Surveyor Capital
GordonMD Global Investments
Doug Leone Family Fund
HRTG Partners
RWN Management
Soley Therapeutics Overview
About Soley Therapeutics
Soley Therapeutics develops drugs using AI-analyzed high-content phenotypic screening of cellular responses via microscopy images. Headquartered in Vienna, Austria, the platform identifies novel therapies for oncology and immunology. The company collaborates with pharma partners on phenotypic assays measuring multi-dimensional drug effects. Founded in 2020, Soley Therapeutics raised seed funding and published findings in Nature Methods.
Founded
2018
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Licensing, Subscription
Soley Therapeutics Funding History
Soley Therapeutics has raised a total of $220M across 2 funding rounds.
Soley Therapeutics' first fundraising round was a $20M undisclosed-stage round in December 2020. The most recent completed round was a $200M Series C in January 2026.
Soley Therapeutics funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jan 2026 | Series C | Surveyor Capital (lead); Breyer Capital; GordonMD Global Investments; RWN Management; HRTG Partners; Doug Leone Family Fund | $200M | Soley Therapeutics announced a $200 million Series C financing on January 7, 2026, to advance its proprietary cell stress sensing platform and pipeline of novel therapeutics into the clinic. The company is a science-first, tech-enabled drug discovery and development firm based in South San Francisco that leverages artificial intelligence and computer vision to analyze thousands of responses in human cells to help design new therapeutic molecules. Surveyor Capital (a Citadel Company) served as the primary investor, joined by new backers HRTG Partners and RWN Management, along with returning existing investors including Doug Leone Family Fund, Breyer Capital, and GordonMD Global Investments. The Series C proceeds will support IND-enabling work and clinical trials for two first-in-class internally discovered and developed oncology assets, with the lead asset for acute myeloid leukemia (AML) on track for IND filing in 2026 and a second asset for solid tumors entering IND-enabling studies. The funding will also advance non-oncology stress-reducing drug candidates for neurodegenerative disorders and metabolic diseases, and continue platform scale-up. The company's cell stress sensing technology measures how living human cells respond to drug exposure and translates this cellular information into a robust portfolio of novel drug candidates across disease areas. |
| Dec 2020 | Undisclosed stage | - | $20M | - |
Who has invested in Soley Therapeutics?
6 investors have backed Soley Therapeutics across its funding rounds, including Breyer Capital, Surveyor Capital, GordonMD Global Investments, Doug Leone Family Fund, HRTG Partners and RWN Management.
Lead investors include Surveyor Capital.
Soley Therapeutics Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | Jan 2026 | ||
| 1 | Participant | Jan 2026 | ||
| 1 | Participant | Jan 2026 | ||
| 1 | Participant | Jan 2026 | ||
This data is available for Pro users. Sign up to see all 6 Soley Therapeutics investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialSoley Therapeutics Competitors
Soley Therapeutics competitors include listed companies like SAP and Snowflake, and private ones like Astromech, Chai Discovery, Anthropic and OpenAI.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $3.8B | - | ||
| Private | $48M | - | $3.8B | - | ||
| Private | $47B | - | $965B | 20.5x | ||
| Private | $25B | - | $852B | 34.1x | ||
| Publicly listed | $42B | $13B | $248B | 5.4x | ||
| Publicly listed | $4.7B | ($1.3B) | $119B | 21.0x |
Soley Therapeutics Public Comps
Soley Therapeutics is still privately-owned, but its public comps include Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche, Novartis, AstraZeneca, CrowdStrike, SAP and Amgen.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $65B | $28B | 16.5x | 13.1x | 38.7x | 27.0x | |||
| $94B | $40B | 7.2x | 6.8x | 17.0x | 18.3x | |||
| $61B | $17B | 8.7x | 8.1x | 30.6x | 17.6x | |||
| $65B | $28B | 6.3x | 6.2x | 14.7x | 21.0x | |||
| $77B | $26B | 5.0x | 4.9x | 14.6x | 12.4x | |||
| $57B | $22B | 5.5x | 5.5x | 14.2x | 13.3x | |||
| $59B | $19B | 4.8x | 4.5x | 14.6x | 12.7x | |||
| $4.8B | ($12M) | 51.4x | 44.5x | (19816.2x) | 151.0x | |||
This data is available for Pro users. Sign up to see all Soley Therapeutics competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Soley Therapeutics
| When was Soley Therapeutics founded? | Soley Therapeutics was founded in 2018. |
| Where is Soley Therapeutics headquartered? | Soley Therapeutics is headquartered in San Francisco, CA, United States. |
| Is Soley Therapeutics publicly listed? | No, Soley Therapeutics is a private, VC-backed company. |
| How much funding has Soley Therapeutics raised? | Soley Therapeutics has raised $220M across 2 funding rounds. |
| What was Soley Therapeutics' last funding round? | Soley Therapeutics' last funding round was a $200M Series C in January 2026, led by Surveyor Capital. |
| Who are Soley Therapeutics' investors? | Soley Therapeutics' investors include Breyer Capital, GordonMD Global Investments, RWN Management, HRTG Partners, Surveyor Capital and Doug Leone Family Fund. |
| Which companies are comparable to Soley Therapeutics? | Companies comparable to Soley Therapeutics include Astromech, Chai Discovery, Anthropic, OpenAI, SAP and Snowflake. |
See companies similar to Soley Therapeutics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




